関連する実験動画
Updated: Jul 15, 2026

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
ダイエットと冠動脈疾患と2型糖尿病のリスク
1Department of Human Nutrition, University of Otago, PO Box 56, Dunedin, New Zealand. jim.mann@stonebow.otago.ac.nz
Lancet (London, England)
|September 21, 2002
まとめ
高濃度飽和脂肪の摂取は,冠動脈疾患 (CHD) と2型糖尿病と関連しています. 肥満と飽和脂肪の減少を含むライフスタイルの変化は,両方の状態を予防するために不可欠です.
科学分野:
- 心血管の健康について
- メタボリック障害 メタボリック障害
- 栄養学的流行病学について
背景:
- 高濃度飽和脂肪の摂取は,冠動脈疾患 (CHD) と2型糖尿病の既知の危険因子です.
- 世界的な傾向は,2型糖尿病の増加と並行して,CHDの割合が減少していることを示し,異なるリスク要因を示唆しています.
- 肥満は,世界中で2型糖尿病率が上昇する主な要因です.
研究 の 目的:
- 冠動脈性心疾患と2型糖尿病の異なる世界的な傾向を調査する.
- これらの傾向に影響を与える主要なライフスタイルの要因を特定する.
- 2型糖尿病とCHDの二重の流行を緩和するための介入を提案する.
主な方法:
- CHDと2型糖尿病の傾向に関する疫学データの分析.
- 心血管と代謝の健康に影響を与える要因のレビュー.
- 疾病リスクに対するマクロ栄養素組成と肥満の影響の評価.
主要な成果:
- 心血管疾患の発生率の低下は,喫煙の減少と心血管ケアの改善に起因する可能性がある.
- 肥満率の増加は,2型糖尿病の増加と強く相関しています.
- 糖尿病に関連した心血管疾患のリスクは,従来の危険因子の改善を相殺する可能性があります.
結論:
- 肥満の減少は,CHDの減少の逆転を防ぐために非常に重要です.
- 飽和脂肪酸の摂取量を減らすことと,肥満を標的としたライフスタイル介入は,2型糖尿病とCHDの流行に対処する鍵です.
関連する概念動画
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

